SCHEMBL26645533

SCHEMBL26645533

CC1c2c(I)c(Br)nn2CCN1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30622817 0.83 ALDH1A1 (0.33) —
SCHEMBL26645255 0.78 SMO (0.34) —
SCHEMBL26645086 0.73 CSNK1E (0.39) —
SCHEMBL26645645 0.71 SMO (0.41) —
SCHEMBL26645369 0.71 — —
SCHEMBL26645043 0.71 — —
SCHEMBL26645373 0.71 — —
SCHEMBL25433103 0.68 GRM5 (0.41) —
SCHEMBL26645168 0.68 GRM5 (0.41) —
SCHEMBL29308619 0.66 MAP4K4 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback